ClinicalTrials.Veeva

Menu

Long-term Prognosis and Valve Durability of TAVR

A

Air Force Military Medical University of People's Liberation Army

Status

Enrolling

Conditions

Aortic Valve Stenosis and Insufficiency

Treatments

Procedure: Transcatheter aortic valve replacement

Study type

Observational

Funder types

Other

Identifiers

NCT06379386
TRACE TAVR Registry

Details and patient eligibility

About

This registry aims to evaluate the long-term prognosis and valve durability of transcatheter aortic valve replacement (TAVR) in a real-world setting. Baseline characteristics, procedural data, and clinical outcomes will be collected in a prospective and observational manner.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients diagnosed with severe aortic valve regurgitation undergo evaluation by the Heart team and are eligible for TAVR therapy.

  1. Patients who understand the purpose of this study, agree to participate in the trial and sign the informed consent form
    1. Patients with aortic stenosis or aortic valve insufficiency who were evaluated by the Heart team and underwent TAVR therapy
    1. Patients who understand the purpose of the study, agree to participate in the trial and sign the informed consent form

Exclusion criteria

    1. Patients who cannot provide informed consent
    1. Patients who are participating in other clinical trials

Trial contacts and locations

1

Loading...

Central trial contact

Rutao Wang, M.D, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems